News
Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million
2+ hour, 53+ min ago (530+ words) London-based BioTech startup Ternary Therapeutics has raised "4.1 million (3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues. The round was led by European venture firm daphni, with participation…...